Skip to main content

Together we are beating cancer

Donate now

For Supporters

Showing 12 out of 133 results
Samra Turajlic (credit: Michael Bowles)

Meet the lead of a new multi-million pound collaboration to make immunotherapy work for more people Meet the lead of a new multi-million pound collaboration to make immunotherapy work for more people

by Krishna Sharma | 23 May 2025

23 May 2025

Iain Foulkes

Cancer Research Horizons, the innovation arm of Cancer Research UK, has launched the Cancer Impact Club, a community of business leaders whose philanthropy, expertise, and networks will help shape the future of cancer treatment. The club has recruited 13 members already, raising £1.3m of its £5m target. Cancer Research Horizons, the innovation arm of Cancer Research UK, has launched the Cancer Impact Club, a community of business leaders whose philanthropy, expertise, and networks will help shape the future of cancer treatment. The club has recruited 13 members already, raising £1.3m of its £5m target.

by Krishna Sharma | Philanthropy and partnerships | 20 March 2025

20 March 2025

Giulia Biffi in the lab. Image credit: David Vintiner.

Garfield Weston Foundation has donated £10m towards our Cancer Impact Booster. The booster aims to help overcome one of the greatest challenges in translating science into new treatments – attracting early-stage investment. Garfield Weston Foundation has donated £10m towards our Cancer Impact Booster. The booster aims to help overcome one of the greatest challenges in translating science into new treatments – attracting early-stage investment.

by Charlotte Mathé | Philanthropy and partnerships | 12 December 2024

12 December 2024

More Research, Less Cancer over an image of a researcher

Chris Gethin is the Director of Philanthropy at Cancer Research UK. Eight months after launching the largest philanthropic campaign by a UK charity, he shares his thoughts on the evolving landscape of high-value giving. Chris Gethin is the Director of Philanthropy at Cancer Research UK. Eight months after launching the largest philanthropic campaign by a UK charity, he shares his thoughts on the evolving landscape of high-value giving.

by Chris Gethin | Philanthropy and partnerships | 10 October 2024

10 October 2024

Researcher at the Crick Skylab.

The Francis Crick Institute and MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)), have opened a new Skylab facility, extending the footprint of the Crick and expanding opportunities for collaboration between the two organisations.  The Francis Crick Institute and MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)), have opened a new Skylab facility, extending the footprint of the Crick and expanding opportunities for collaboration between the two organisations. 

by Krishna Sharma | 5 September 2024

5 September 2024